The company is substantially advanced this development of the innovative therapy for ATTR-CM, employing the investigational drug. Preliminary trial information reveals potential benefits for those diagnosed from the https://attrcm837149.mybuzzblog.com/22233346/bridgebio-progresses-attr-cm-therapy-with-attruby